Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL

NCT02690545 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma
Lymphoma, Non-Hodgkin
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type

Interventions

BIOLOGICAL: ATLCAR.CD30 cells

Sponsor

UNC Lineberger Comprehensive Cancer Center